- Home
- LIQT vs ESLA Comparison
LIQT vs ESLA Comparison
Compare LIQT & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LIQT | ESLA |
|---|---|---|
| Founded | 2004 | 2021 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2M | 19.1M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LIQT | ESLA |
|---|---|---|
| Price | $0.40 | $0.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 148.4K | ★ 179.9K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $21.16 | N/A |
| Revenue Next Year | $22.50 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.42 | $0.31 |
| 52 Week High | $3.35 | $3.15 |
Technical Indicators
Market Signals| Indicator | LIQT | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 36.35 | 18.50 |
| Support Level | $0.42 | N/A |
| Resistance Level | $0.71 | $0.51 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 3.01 | 10.60 |
Price Performance
Historical ComparisonAbout LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is renowned in three business areas: ceramic membranes and membrane incorporated liquid filtration systems, ceramic diesel particulate filters (DPFs) to control soot exhaust particles and black carbon emission from diesel engines, and plastic components for usage across various industries. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, Hybrid Technology Membranes and others. The Company operates through three reportable segments: Systems and Aftermarket, Filters and Membranes, and Components.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.